DMIIU Drugs Made In America Acquisition II Corp. - Unit

NAS · US · Financial Services · Shell Companies

10.20USD-0.10%Mkt Cap: —P/E: —6d ago

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other si…

Industry Peers

Shell Companies

Armada Acquisition Corp. II

$790.07MUSDP/E 227.4

DMII

Drugs Made In America Acquisition II Corp.

$649.10MUSDP/E 34.0

CCXI

Churchill Capital Corp XI

$626.07MUSD

EVAC

EQV Ventures Acquisition Corp. II

$602.60MUSDP/E 34.4

BCSS

Bain Capital GSS Investment Cor

$596.85MUSD

CXII

Churchill Capital Corp XII

$591.61MUSD

CEPF

Cantor Equity Partners IV, Inc.

$586.93MUSDP/E 31.1

AC8

Intuitive Investments Group Plc

$532.06MUSDP/E 2.5

AEXA

American Exceptionalism Acquisition Corp. A

$536.65MUSD

NWAX

New America Acquisition I Corp.

$500.24MUSD

AAC

Ares Acquisition Corporation III

$496.66MUSD

MLAA

Mountain Lake Acquisition Corp. II

$490.34MUSD

KRSP

Rice Acquisition Corporation 3

$486.71MUSD

BRTM

B&R Technology Merger Corp.

$478.69MUSD

CRAN

Crane Harbor Acquisition Corp. II

$473.69MUSD

GTEN

Gores Holdings X, Inc.

$470.58MUSDP/E 21.3

GCGR

General Catalyst Global Resilience Merger Corp.

$467.87MUSD

APXT

Apex Treasury Corporation

$466.49MUSD

BCCQ

Bleichroeder Acquisition Corp. III

$457.24MUSD

Key Statistics

Company

Market Cap—

Enterprise Value650.02M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)4.19M USD

Revenue/Share—

Last Price10.20 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-36.30

EPS (TTM)—

EPS (Forward)—

52W Range

9.93531% of range10.80

52W High10.80 USD

52W Low9.935 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE0.86%

ROA0.83%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.02M USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt275.03K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.34

Quick Ratio0.27

Book Value/Sh-0.28 USD

Cash/Share0.0030 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float54.01M

Insiders1.07%

Institutions5.46%

Short Interest

Short Ratio14.3d

Shares Short1.19K

Short (prev mo.)1.34K

Technical

SMA 5010.19 (+0.1%)

SMA 20010.11 (+0.9%)

Beta—

S&P 52W Chg15.78%

Avg Vol (30d)330

Avg Vol (10d)540

Technical Indicators

RSI (14)49.0

MACD0.0027

MACD Signal0.0058

MACD Hist.-0.0031

BB Upper10.24 USD

BB Middle10.21 USD

BB Lower10.18 USD

BB Width0.62%

ATR (14)0.0096 USD

Vol Ratio (20d)0.00x